A phase 1-2, multicenter, randomized, double-blind, placebo controlled, prospective study to evaluate the safety and potential efficacy of single, increasing doses of TG100-115 in subjects undergoing percutaneous coronary intervention for acute anterior ST elevation myocardial infarction

Trial Profile

A phase 1-2, multicenter, randomized, double-blind, placebo controlled, prospective study to evaluate the safety and potential efficacy of single, increasing doses of TG100-115 in subjects undergoing percutaneous coronary intervention for acute anterior ST elevation myocardial infarction

Active, no longer recruiting
Phase of Trial: Phase I/II

Latest Information Update: 10 Oct 2005

At a glance

  • Drugs TG 100115 (Primary)
  • Indications Myocardial infarction
  • Focus Adverse reactions
  • Most Recent Events

    • 10 Oct 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top